Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2026-02-26 @ 11:04 AM
Study NCT ID:
NCT02195869
Status:
COMPLETED
Last Update Posted:
2019-07-11
First Post:
2014-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Sponsor:
Pharmacyclics LLC.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Graft Versus Host Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | PCYC1129 | View |
| None | PCYC1129CA | View |
| None | 1129 | View |
| None | Ibrutinib | View |
| None | PCI32765 | View |
| None | IMBRUVICA | View |
| None | Pharmacyclics | View |
| None | PCYC | View |
| None | GVHD | View |
| None | Steroid dependent | View |
| None | refractory | View |
| None | chronic | View |
| None | graft versus host disease | View |
| None | chronic graft versus host disease | View |
| None | immunology | View |